Striking effect of hydroxamic acid substitution on the phosphodiesterase type 4 (PDE4) and TNF alpha inhibitory activity of two series of rolipram analogues: implications for a new active site model of PDE4.
作者信息
Kleinman E F, Campbell E, Giordano L A, Cohan V L, Jenkinson T H, Cheng J B, Shirley J T, Pettipher E R, Salter E D, Hibbs T A, DiCapua F M, Bordner J
机构信息
Central Research Division, Pfizer Inc., Groton, Connecticut 06340, USA.
出版信息
J Med Chem. 1998 Jan 29;41(3):266-70. doi: 10.1021/jm970685m.
PMID:9464356
Abstract
摘要
Zotero 插件